Infusion pump with occlusion detection function

JP2023552830A5Inactive Publication Date: 2024-11-22SMITHS MEDICAL ASD INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023534967
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-12-09
Filing Date
2021-11-15
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing infusion pumps, particularly syringe and microinfusion pumps, face challenges in accurately detecting occlusions, which can lead to incomplete drug delivery and potential harm to patients due to delayed detection and large fluid boluses when occlusions are resolved.

Method used

The system employs a mathematical model to predict frictional forces and pressure changes during infusion, using sensors to detect deviations and trigger alarms, and incorporates Bayesian inference to enhance occlusion detection accuracy and speed.

Benefits of technology

The solution provides faster occlusion detection, reduces nuisance alarms, and minimizes the risk of large fluid boluses by accurately identifying blockages in infusion systems.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

1. An occlusion detection system comprising: a cartridge containing an infusion solution; a plunger driven by a drive mechanism configured to advance within the cartridge to expel the infusion solution from the cartridge; a force sensor configured to sense an actual force exerted by the plunger; and a control unit configured to determine an estimated force based on a predicted decay of frictional force between the plunger and the cartridge to compare with the actual force sensed by the force sensor, wherein an occlusion alarm is triggered when a deviation between the estimated force and the actual force exceeds a threshold.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] FIELD OF THE DISCLOSURE The present disclosure relates generally to infusion pump systems, and more particularly to systems and methods for occlusion detection. [Background technology]

[0002] Various types of infusion pumps have been useful for managing the delivery and distribution of predetermined amounts or doses of medications, fluids, fluid-like substances, or infusions (collectively referred to herein as "infusions") to patients. Infusion pumps offer significant advantages over manual administration by precisely delivering infusions over extended periods of time. Infusion pumps are particularly useful in the treatment of diseases and disorders requiring regular pharmacological intervention, such as cancer, diabetes, vascular disorders, neurological disorders, and metabolic disorders. Infusion pumps also enhance healthcare professionals' ability to administer anesthesia and manage pain. Infusion pumps are used in a variety of settings, including hospitals, nursing homes, other short- and long-term care facilities, and residential care settings. There are many types of infusion pumps, including portable, large-volume, patient-controlled anesthesia (PCA), elastomeric, syringe-type, enteral, and insulin pumps. Infusion pumps can be used to administer medications via a variety of delivery methods, including intravenous, intraperitoneal, intra-arterial, intradermal, subcutaneous, juxta-neural, intraoperative, epidural, and subarachnoid delivery.

[0003] In the field of drug delivery devices and systems, including so-called "syringe pumps," a pre-filled medication syringe is typically mechanically driven under microprocessor control to deliver a predetermined amount of medication to a patient at a controlled rate through an infusion line fluidly connected to the syringe. Syringe pumps typically include a motor that rotates a lead screw. The lead screw actuates a plunger driver, which pushes a plunger in the syringe barrel forward with a thumb. Thus, pushing the plunger forces a dose of medication outward from the syringe, into the infusion line, and into the patient's vein. Examples of syringe pumps are described, for example, in U.S. Pat. No. 8,182,461, entitled "Syringe Pump Rapid Occlusion Detection System," and U.S. Pat. No. 10,004,847(B2), entitled "Occlusion Detection," the contents of which are incorporated herein by reference. As used throughout this disclosure, the term "syringe pump" is intended to generally refer to any device that acts on a syringe to controllably force fluid outward therefrom.

[0004] Micro infusion pumps (also known as "burst pumps") have been developed as a subset of syringe pumps. Micro infusion pumps are small, typically portable pumps that can be placed very close to the patient's injection site, such as by being carried under the patient's clothing. Micro infusion pumps are capable of reliably delivering low infusion rates and are often used continuously for multiple days. In some cases, the pumps utilize a replaceable syringe-like cartridge into which a plunger advances to administer the infusion. To maintain long battery life, micro infusion pump systems typically deliver infusion fluid in relatively short, short bursts, or "bursts," representing very small advances of the plunger within the cartridge (e.g., 3 μm or less), with relatively long pauses between bursts and low power consumption.

[0005] Various types of syringe pumps have been used in medical practice for many years, but manufacturers of these devices are constantly striving for more efficient, effective, and safer methods of use. In some cases, infusion pumps, such as traditional syringe pumps and microinfusion pumps, can experience blockages. In medical technology, the term "blockage" refers to a blockage or restriction of a normally open passageway. In some cases, an occlusion may be desired, such as when a physician intentionally pinches or temporarily blocks a catheter during a medical procedure. In other instances, an unintended blockage can occur when the intended, commanded forward progression of a plunger through a syringe or cartridge barrel is impeded or when the intended outward flow of infusion fluid from the pump to the patient is impeded, such as when the infusion line tubing is kinked or structurally obstructed to some degree. If the blockage goes unnoticed, the patient likely will not receive the prescribed infusion, potentially leading to serious consequences.

[0006] As such, attempts have been made to sense or detect occlusions in medical devices. For example, some syringe pumps detect occlusions using a pressure sensor that senses the force exerted by the thumb of the syringe on the plunger driver. When the force sensed by the pressure sensor exceeds a predetermined threshold, a processor connected to the pressure sensor generates a signal indicating that an occlusion may have occurred or is occurring. Nevertheless, further advances in occlusion detection are desired. The present disclosure addresses one or more of these concerns. Summary of the Invention

[0007] The occlusion detection systems and methods described in detail herein by way of example make novel and inventive use of input parameters such as variations in frictional force between the plunger and syringe cartridge during operational use. In some embodiments, such compensation for expected changes in frictional force advantageously results in more accurate pressure detection, reduced time required to identify the presence of an occlusion, and greater confidence in occlusion detection.

[0008] One embodiment of the present disclosure provides a system for occlusion detection, the system comprising: a cartridge containing an infusion solution; a drive mechanism configured to advance a plunger within the cartridge to expel the infusion solution from the cartridge; a force sensor configured to sense an actual force applied by the plunger; and a control unit configured to determine an estimated force based on a predicted decay of frictional force between the plunger and the cartridge to compare with the actual force sensed by the force sensor, the control unit triggering an occlusion alarm when a deviation between the estimated force and the actual force exceeds a threshold value.

[0009] In one embodiment, the estimated force is based on a mathematical model used to predict the expected friction force decay during actuation of the drive mechanism. In an embodiment, the mathematical model is a two-exponential equation. In one embodiment, the mathematical model is represented by the equation F(t)=C0+C1^(-((t-t0)) / t1)+C2^(-((t-t0)) / t2). In an embodiment, the estimated force is based on one or more input parameters measurable by the system. In an embodiment, the input parameters include at least one of the actual force sensed by a force sensor at the end of actuation of the drive mechanism and / or one or more material compliances of the system.

[0010] Another embodiment of the present disclosure provides a system for occlusion detection, the system comprising: a cartridge containing an infusion solution; a drive mechanism configured to advance a plunger within the cartridge to expel the infusion solution from the cartridge; a force sensor configured to sense the actual force applied by the plunger; and a control unit configured to plot a trend line by connecting the force sensed by the force sensor at a moment in a burst cycle over a series of burst cycles, wherein a slope of the trend line exceeding a threshold triggers an occlusion alarm. In one embodiment, each burst cycle is represented by a period between actuations of the drive mechanism, beginning and ending upon cessation of actuation of the drive mechanism. In an embodiment, the trend line is fitted to an average of the pressure sensed at the cessation of actuation of the drive mechanism. In an embodiment, a positive slope of the trend line indicates an occlusion.

[0011] Another embodiment of the present disclosure provides a method for detecting occlusion, the method including estimating system compliance, calculating a probability of system occlusion, and triggering at least one of an occlusion alarm, alert, or notification upon determining that the calculated probability of system occlusion exceeds a threshold. In one embodiment, the system compliance is calculated by measuring reduced pressure after deactivation of the drive mechanism. In one embodiment, the system compliance is calculated as a function of predicted friction force decay. In one embodiment, the system compliance is calculated by dividing the change in pressure measured by the force sensor by the change in fluid volume. In one embodiment, calculating the probability of system occlusion includes Bayesian inference.

[0012] The above summary is not intended to describe each illustrated embodiment or every embodiment of the present disclosure, the following figures and detailed description more particularly exemplify these embodiments. [Brief explanation of the drawings]

[0013] The present disclosure may be more fully understood from consideration of the following detailed description of various embodiments of the disclosure in connection with the accompanying drawings, in which: [Figure 1] FIG. 1 is a perspective view illustrating an infusion pump system attached to a patient, according to an embodiment of the present disclosure. [Figure 2] FIG. 2 is an exploded perspective view illustrating an infusion pump according to an embodiment of the present disclosure. [Figure 3] FIG. 3 is a graph illustrating the increase in frictional force during advancement of a plunger within a cartridge, according to an embodiment of the present disclosure. [Figure 4] FIG. 4 is a graph illustrating the natural decay of friction force during a plunger "burst" according to an embodiment of the present disclosure. [Figure 5] FIG. 5 is a graph illustrating a trend line across sensed force readings at a moment in time within each burst cycle over a series of burst cycles, in accordance with an embodiment of the present disclosure. [Figure 6] FIG. 6 is a flowchart illustrating a method for occlusion detection using Bayesian inference, according to an embodiment of the present disclosure. [Figure 7A] FIG. 7A is a graph depicting distribution curves of cartridge compliance and system compliance according to an embodiment of the present disclosure. [Figure 7B] 7B is a graph showing the average distribution curve of the combined cartridge compliance and system compliance of FIG. 7A according to an embodiment of the present disclosure. While embodiments of the present disclosure are susceptible to various modifications and alternative forms, details thereof shown by way of example in the drawings will be described. It should be understood, however, that it is not intended to limit the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the subject matter defined by the claims. DETAILED DESCRIPTION OF THE INVENTION

[0014] 1, an infusion pump system 100 for administering an infusion fluid to a patient (P) is shown, according to one embodiment of the present disclosure. The infusion pump system 100 may include an infusion pump 102 configured to control the delivery of an infusion fluid to the patient P via an infusion set 104 or other tubing fluidly coupled between the pump 102 and the patient P.

[0015] 2, an exploded perspective view of an infusion pump 102 is shown in accordance with an embodiment of the present disclosure. In an embodiment, the infusion pump 102 can include a front housing 108A and a rear housing 108B configured to provide a chassis onto which other components of the infusion pump 102, such as a drive mechanism 110, a power supply 112, a control unit 114, a memory 115, and a graphical user interface 116, can be assembled.

[0016] The infusion pump 102 may further include or be operably coupled to a cartridge 118 containing an infusion fluid, which may include a plunger 120 for expelling the infusion fluid therefrom. The cartridge 118 may be any suitable syringe-like object, container, or other source for containing or delivering an infusion volume. In some embodiments, the cartridge 118 may be selectively removed and replaced as needed, such as when the supply of infusion fluid therein is depleted. An infusion set connector 122 may fluidly couple a dispensing end 124 of the cartridge 118 to the infusion set 104.

[0017] Plunger 120 may be driven by drive mechanism 110, for example, via a lead screw arrangement configured to cooperatively actuate plunger 120, thereby driving fluid from cartridge 118. Drive mechanism 110 may be powered by power source 112. In some embodiments, power source 112 may be in the form of one or more disposable or rechargeable batteries, which may be selectively removed and replaced via battery door 126. Drive mechanism 110 may be controlled via control unit 114.

[0018] The control unit 114 may be any suitable programmable device configured to accept digital data as input, process the input according to instructions or algorithms, and provide a result as output. In one embodiment, the control unit 114 may be a central processing unit (CPU) configured to execute instructions of a computer program. In one embodiment, the control unit 114 may be an advanced RISC (Reduced Instruction Set Computing) Machine (ARM) processor or other embedded microprocessor. In an embodiment, the control unit 114 comprises a multi-processor cluster. Thus, the control unit 114 may be configured to perform at least basic arithmetic, logical, and input / output operations.

[0019] Memory 115 may comprise volatile or non-volatile memory, as required by the coupled control unit 114, to provide space for executing instructions or algorithms as well as for storing the instructions themselves. In embodiments, volatile memory may include, for example, random access memory (RAM), dynamic random access memory (DRAM), or static random access memory (SRAM). In embodiments, non-volatile memory may include, for example, read-only memory, flash memory, ferroelectric RAM, hard disk, floppy disk, magnetic tape, or optical disk storage. The foregoing examples are not intended to limit the types of memory that may be used, as the embodiments are given by way of example only and are not intended to limit the subject matter herein.

[0020] The control unit 114 may receive input from a graphical user interface 116, which in an embodiment may be a touchscreen input and display system. In an embodiment, the control unit 114 may communicate with an antenna 128 configured to wirelessly transmit and receive data to and from one or more external computing devices, such as a mobile computing platform (e.g., a smartphone, a tablet, a personal computer, etc.) and / or a network. In one embodiment, the antenna 128 may be an RFID coil, although other types of antennas are contemplated.

[0021] In one embodiment, the control unit 114 can additionally receive inputs from other input devices, sensors, and monitors, such as a sensor 130. In some embodiments, the sensor 130, which may be located in-line with the drive mechanism 110, can be configured to monitor the force between the drive mechanism 110 and the plunger 120 and / or the position of the plunger 120 relative to the cartridge 118 according to system specifications. The sensor 130 can comprise a force sensor, a pressure sensor, a distance sensor, a proximity sensor, or any other suitable sensor. In some embodiments, the sensor 130 can further function as an occlusion detection sensor configured to sense when the fluid pressure of the infusion solution exceeds a predetermined threshold, thereby indicating a possible occlusion in the cartridge 118 and / or the infusion set 104.

[0022] The infusion pump 102 shown in Figures 1 and 2 is one example of a portable pump that can be used to provide a wide range of therapies and treatments. Such portable pumps can be comfortably worn or otherwise removably coupled to a user by a belt, strap, clip, or other simple fastening mechanism for outpatient care at home, or can be mounted on a walking pole in hospitals and other medical facilities.

[0023] In one embodiment, infusion pump 102 may be a burst or micro infusion pump configured to intermittently infuse small amounts of medication over an extended period of time. In a non-limiting embodiment, infusion pump system 100 may be configured to subcutaneously or intravenously administer treprostinil (sold under the trade name Remodulin® by United Therapeutics) or other medication for the treatment of pulmonary arterial hypertension (PAH), although administration of infusions other than treprostinil is also contemplated.

[0024] The embodiment of the infusion pump 102 shown in FIGS. 1 and 2 is provided by way of example only and is not intended to limit the scope of the subject matter herein. Other types of pumps and other pump configurations may be utilized in various embodiments. Furthermore, it should be understood that the systems and methods described herein, particularly those configured to identify an occlusion between a plunger and an infusion container or cartridge, are equally applicable to other types of infusion pumps, particularly syringe pumps and other types of infusion pumps configured to administer infusion fluid via an advancing plunger within a syringe, cartridge, or other container containing the infusion fluid, such as those disclosed in U.S. Pat. No. 8,182,461 entitled "Syringe Pump Rapid Occlusion Detection System" and U.S. Pat. No. 10,004,847 (B2) entitled "Occlusion Detection," both of which are incorporated by reference above.

[0025] Occlusion detection is typically performed by estimating the pressure within the cartridge 118 and / or infusion set 104 and issuing a warning, alarm, or notification when that value exceeds a set limit. With low drug flow rates, such as with micro infusion pumps or burst pumps, such conventional methods may take an excessively long time for an occlusion to be detected. Even after an occlusion is detected and the drive mechanism 110 is stopped, the pressure within the infusion set 104 between the occlusion and the drive mechanism 110 remains at an elevated pressure (e.g., the pressure at the time the drive mechanism 110 was stopped). If the occlusion is suddenly relieved (e.g., an infusion line is suddenly unkinked), the pressurized fluid may be delivered to the patient as a large bolus of infusion, which may be dangerous depending on the type of infusion. Embodiments of the present disclosure address these issues.

[0026] 1. Parameter-dependent friction model One source of significant error in pressure estimation for burst pumps is the variation in friction that typically occurs between the walls of the cartridge 118 and the plunger 120. The variation in friction force during the advancement of the plunger 120 can be significant due to many factors, including, but not limited to, the distance traveled by the plunger 120 during the current "burst," material compliance, and the normal force applied to the plunger 120. Referring to FIG. 3, a graph is shown illustrating an example of the increase in friction force 200A during the advancement of the plunger 120 within the cartridge 118, in accordance with an embodiment of the present disclosure. As shown in the graph of FIG. 3, the X-axis represents time (seconds) and the Y-axis represents force (Newtons).

[0027] Once the plunger 120 stops moving (e.g., at the completion of the "burst"), the frictional force built up during the advancement of the plunger 120 naturally decays over time. The rate and magnitude of decay is largely based on many factors, including, but not limited to, material properties, distance traveled, time, and other factors. Referring to FIG. 4, a graph is shown illustrating an example of the decay of frictional force 200B during a plunger "burst" in accordance with an embodiment of the present disclosure. As shown in the graph of FIG. 4, the X-axis represents time (seconds) and the Y-axis represents force (Newtons).

[0028] In some embodiments, curve 202 can be fitted to the actual measured decay of friction force 200B, and curve 202 can be represented by a mathematical model. The mathematical model can then be used to predict the future or expected decay of the friction force between plunger bursts. For example, in one embodiment, the mathematical model can be represented by the following two exponential equations:

number

[0029] where F(t) represents the value of the friction force at a moment in time t (e.g., corresponding to curve 202) occurring after the motor has stopped t, and C, C, and C represent constants that can be determined through various mathematical processes to curve-fit the predicted decay time t of the friction force to the actual, measured, or experimental decay of the friction force.

[0030] While the predicted friction force F(t) is expressed as a function of time t, there are many input parameters that are considered when determining the constants C0, C1, and C2. For example, as previously mentioned, these input parameters may include, among other factors, the distance traveled by the plunger 120 during the previous burst, the normal force exerted on the plunger 120 at the end of the burst, and the material compliance of the system (e.g., the material properties of the plunger 120, cartridge 118, and / or extension set 104).

[0031] In some embodiments, each of the constants C0, C1, and C2 can be written as a function of these input parameters. For example, C0 can be expressed as:

number

[0032] where d represents the distance traveled by plunger 120 during the previous burst, and F burst represents the normal force applied to the plunger 120 at the end of the burst, and (...) represent other input parameters that are considered in determining the constant C0. Depending on the specific input parameters (e.g., the distance traveled by the plunger 120 (d) and the normal force applied to the plunger 120 at the end of the burst (F burst )) are measurable by the system, the predicted friction force F(t) at any given instant in time t can be expressed as a function of both time t and the measured input parameters. For example, in some embodiments, the predicted friction force F(t) can be expressed as:

number

[0033] Thus, in some embodiments, the determination of the predicted friction force decay F(t) (e.g., corresponding to curve 202) can use known or estimated relationships between input parameters known to affect the friction force decay between burst cycles. Including these input parameters in the prediction of friction force decay can allow for more accurate pressure detection, resulting in clinical benefits such as fewer nuisance alarms and faster time to occlusion.

[0034] 2.Detection of blockage by measuring pressure reduction after motor stop In some embodiments, the predicted friction force decay 202 can be used as an aid in determining natural fluctuations in pressure in the cartridge 118 during operation. For example, in some embodiments, the infusion pump 102 can include a force sensor 130 configured to sense the force experienced by the plunger 120. Dividing the sensed force by the area within the cartridge cylinder 118 according to the formula P=F / A yields the pressure within the cartridge cylinder 118. By considering the actual or predicted decay of the friction force (an equal and opposite reaction that should be measurable by the force sensor 130), the predicted changes in pressure within the cartridge cylinder 118 over time can be more clearly understood.

[0035] When the motor 110 of the infusion pump 102 stops moving (e.g., at the completion of a burst), the buildup of pressure within the cartridge 118 typically causes fluid to flow out of the cartridge 118 and associated extension set 104 and into the patient, thereby reducing the pressure within the cartridge 118. If sufficient time elapses between bursts, in the absence of an occlusion, the pressure within the cartridge 118 will reduce to an equilibrium pressure (e.g., determined by the patient's fluid pressure or tissue resistance) and further fluid flow from the cartridge 118 will cease. However, if the system 100 is occluded, the pressure will only reduce slightly (e.g., as a result of material compliance and frictional damping) and will never reach the ambient equilibrium pressure.

[0036] As briefly described above, the system can be configured to monitor the pressure in cartridge 118 (e.g., via sensor 130) for a period of time after motor 110 is stopped (e.g., at the completion of a burst) to determine whether the drop in pressure is characteristic of an occluded or unoccluded system 100. In some embodiments, determining whether the drop in pressure is characteristic of an occluded or unoccluded system can be done by comparing the actual change in pressure to an expected change in pressure, which can be determined based on an expected decay of frictional forces.

[0037] In some embodiments, determining whether a pressure decrease is characteristic of an occluded or unoccluded system 100 can be done by comparing the amount of relaxation to some expected amount of relaxation (e.g., the amount of relaxation expected by an expected friction force decay) or by using that information to calculate a characteristic system parameter (in this case, system compliance). System compliance can be calculated according to the following equation:

number

[0038] Here, β est is the estimated system compliance, and ΔF relax is the change in friction force (e.g., as previously described), and ΔF measured is the measured or sensed change in plunger force, ΔV is the volume delivered in the burst, and A cartridgeis the area of ​​the cartridge 118. The estimated system compliance can then be compared to an expected value, either directly or through Bayesian inference. In some embodiments, following this method to determine whether a drop in pressure is characteristic of an obstructed or unobstructed system 100 not only reduces the time before an obstruction determination is made, but can also reduce the size of the bolus administered to the patient if the obstruction is resolved rather suddenly.

[0039] 3. Occlusion detection by pressure trend Occlusion detection by conventional methods (e.g., sensing pressure within the cartridge 118 and / or administration set 104 and providing an occlusion alarm when the sensed pressure exceeds a predetermined limit) can take an inordinately long time before an occlusion is determined, especially at low flow rates. Furthermore, by the time an occlusion is determined, the amount of pressurized infusate trapped within the cartridge 118 and / or administration set 104 for the time required to determine that an occlusion exists can result in a large bolus being delivered to the patient upon removal of the occlusion.

[0040] To reduce the time period required to determine the presence of an occlusion, in some embodiments, the system 100 can use an optimized gradient-based method for determining the presence of an occlusion, whereby as the pressure in the cartridge 118 and / or administration set 104 fluctuates during operation, a trending increase in pressure (e.g., as measured at a point in the operating cycle of the system 100) can trigger an occlusion alarm.

[0041] 5, a trend line 302 may be created during pump operation by connecting sensed force readings 300 at a given moment within each burst cycle 304 over a series of burst cycles. In some embodiments, sensed force readings 301A-C may be taken immediately before a burst to reduce noise in the sensed force. Noise in the sensed force is most likely to occur during a power cycle (e.g., during the normal decay of fluid pressure within the cartridge 118 and / or administration set 104). A trend line 302 with a positive slope above a predetermined threshold may indicate an occlusion.

[0042] In some embodiments, the change in pressure can be divided by the volume of fluid delivered during the measurement according to the following formula:

number

[0043] Dividing the change in pressure by the change in volume has the advantage of normalizing the change in pressure, which in some embodiments may correspond to an estimated system compliance that is used to predict occlusion.

[0044] In some embodiments, monitoring the trend pressure 302 to determine whether the pressure in the cartridge 118 and / or administration set 104 at a given moment in the burst cycle 304 is generally increasing during operation can result in not only a reduction in the time until an occlusion is determined, but also a reduction in the size of any bolus administered to the patient if the occlusion is rather suddenly cleared.

[0045] 4. Bayesian Occlusion Detection In some embodiments, the probability or likelihood that an obstruction has occurred (or that an obstruction is about to be triggered) can be calculated according to a Bayesian inference algorithm. Bayesian inference is a formal expression of "educated guess," in which the likelihood of a condition or event is estimated given some data received by the algorithm. In some embodiments, a Bayesian inference algorithm can be used to determine whether a system is obstructed or not based on data received about one or more known system parameters (e.g., system compliance). In some embodiments, a Bayesian inference algorithm can reduce nuisance alarms and the time required to trigger an obstruction alarm by providing a logical way to incorporate additional knowledge about the system into the obstruction detection method.

[0046] 6, a flow chart illustrating a method 400 for occlusion detection using Bayesian inference is shown, according to one embodiment of the present disclosure. At 402, an estimated system compliance (β est ) is determined. For example, in embodiments, the estimated system compliance may be calculated according to at least one of reduced pressure measurements after motor shutdown, pressure trends, and / or some other method.

[0047] The estimated system compliance (β est ) at 404, the probability that the system is blocked (P(occluded|β est ) is calculated. In this step, additional information about the system (e.g., material compliance of system components) can be used to improve detection of actual occlusions. For example, if the occlusion occurs proximate to the outlet of the cartridge, the estimated system compliance will be approximately equal to the compliance of the cartridge alone (e.g., "cartridge compliance"). However, if the occlusion occurs proximate to the end of the infusion set, the estimated system compliance will be approximately equal to the compliance of both the cartridge and the infusion set (e.g., "system compliance").

[0048] With further reference to FIG. 7A , distribution curves for cartridge compliance 500A and system compliance 500B are plotted adjacent to each other, taking into account the standard deviation of the error (e.g., material variations over a temperature range, etc.). As shown in the graph of FIG. 7A , the Y-axis indicates the range of compliance values, and the X-axis indicates the probability of measuring any particular compliance value, for example, for an occlusion proximate the outlet of cartridge 118, and for example, for an occlusion proximate the end of infusion set 104, respectively. Given that there is typically no way to know with certainty where an occlusion may occur within a system, the actual compliance value of an occlusion can take any value between the two distributions 500A-B. Therefore, with further reference to FIG. 7B , the probability or likelihood of any occlusion compliance value occurring between cartridge compliance 500A and system compliance 500B can be assumed to be the average of the two peaks.

[0049] Thus, in one embodiment, the probability or likelihood that the system 100 is occluded may be calculated according to the following formula:

number

[0050] Here, "|" is interpreted as "given" and the left side of the equation (i.e., P(occluded|β est )) is the estimated system compliance (β est ) represents the probability that the system is actually occluded. Furthermore, P(occluded) is the probability that the system is actually occluded given the previously calculated P(occluded|β est ), or some initial starting value. That is, initially, we can assume a starting value for P(occluded), and then we can use a new β est When the measurement is made, the previously calculated P(occluded|β est ) can be used. P(β est|occluded) is the probability determined in the previous step, and P(β est ) is a normalization factor used to control the responsiveness of the algorithm.

[0051] Therefore, in some embodiments, the probability that the system 100 is occluded P(occluded|β est ) is the system compliance value β when the system 100 knows that there is an occlusion anywhere between the outlet of the cartridge 118 and the end of the infusion set 104. est represents the likelihood (in step 502) of determining 406. At 406, a probability determination above a threshold (e.g., equal to or greater than about 0.85) may trigger an occlusion alarm, alert, or notification. A probability determination below the threshold may be considered noise.

[0052] A notable advantage of using Bayesian inference is that it can reduce noise in the system by using system information (e.g., characteristic distributions of compliance, system pressure, or other measurable properties) to ignore system measurements that are invalid because they are too low to be characteristic of an obstruction or too high to be characteristic of spurious noise. Bayesian inference can therefore be used to reduce nuisance alarms and / or to shorten the time required to determine an obstruction (to reduce the size of the bolus administered to the patient if the obstruction is resolved rather suddenly). Advantageously, Bayesian inference can be used to reduce the β est Multiple occlusion algorithms can also work together, since any algorithm that estimates a value can be used to update the current probability estimate.

[0053] While the system and method for occlusion detection has been particularly shown and described with reference to the accompanying figures and specification, it will be understood that other modifications thereto are of course possible, all of which are intended to be within the true spirit and scope of the novel and inventive system and method described herein. Accordingly, the construction and design of the various features may be modified or varied depending upon the particular embodiment.

[0054] Various embodiments of systems, devices, and methods have been described herein. These embodiments are provided by way of example only and are not intended to limit the scope of the claimed subject matter. Furthermore, it should be understood that various features of the described embodiments can be combined in various ways to produce numerous additional embodiments. Furthermore, while various materials, dimensions, shapes, configurations, locations, etc. have been described for use with the disclosed embodiments, others than those disclosed may be utilized without departing from the scope of the claimed subject matter.

[0055] Those skilled in the relevant art will recognize that the subject matter herein may include fewer features than are exemplified in the individual embodiments described above. The embodiments described herein are not intended to be an exhaustive listing of ways in which various features of the subject matter herein can be combined. Thus, the embodiments are not mutually exclusive combinations of features; rather, various embodiments may include combinations of different individual features selected from different individual embodiments, as would be understood by one of ordinary skill in the art. Furthermore, elements described with respect to one embodiment can be implemented in other embodiments even if not described in such embodiment, unless otherwise specified.

[0056] Although a dependent claim may refer to a specific combination with one or more other claims, other embodiments may also include combinations of the dependent claim with the subject matter of each other dependent claim, or combinations of one or more features with other dependent or independent claims, and such combinations are suggested herein unless it is stated that a specific combination is not intended.

[0057] The incorporation by reference of the above documents is limited so that no subject matter contrary to the express disclosure of this specification is incorporated. The incorporation by reference of the above documents is further limited so that no claims contained in the documents are incorporated herein by reference. The incorporation by reference of the above documents is further limited so that any definitions set forth in the documents are not incorporated herein by reference, unless expressly included herein.

[0058] For purposes of claim construction, it is expressly intended that the provisions of 35 U.S.C. § 112(f) will not be invoked unless the specific terms "means for" or "step for" appear in the claim.

Claims

1. a cartridge for containing an infusion solution; a plunger driven by a drive mechanism configured to advance within the cartridge to expel the infusion fluid from the cartridge; a force sensor configured to sense an actual force exerted by the plunger; a control unit configured to determine an estimated force based on a predicted decay of a frictional force between the plunger and the cartridge for comparison with the actual force sensed by the force sensor, the control unit triggering an occlusion alarm when a deviation between the estimated force and the actual force exceeds a threshold; 1. An occlusion detection system comprising:

2. The system of claim 1 , wherein the estimated force is based on a mathematical model used to predict expected frictional force decay during operation of the drive mechanism.

3. The system of claim 2 , wherein the mathematical model is a two exponential equation.

4. The mathematical model is expressed by the formula F(t) = C 0 +C 1 ^(-((t-t 0 )) / t 1 ) + C 2 ^(-((t-t 0 )) / t 2 2. The system of claim 1 , wherein:

5. The system of claim 1 , wherein the estimated force is based on one or more input parameters measurable by the system.

6. The system of claim 1, wherein input parameters include at least one of the actual force sensed by the force sensor at the end of operation of the drive mechanism and / or one or more material compliances of the system.

7. a cartridge for containing an infusion solution; a plunger driven by a drive mechanism configured to advance within the cartridge to expel the infusion fluid from the cartridge; a force sensor configured to sense an actual force exerted by the plunger; a control unit configured to plot a trend line by connecting the force sensed by the force sensor at a moment in a burst cycle over a series of burst cycles, wherein a slope of the trend line exceeding a threshold triggers an occlusion alarm; and 1. An occlusion detection system comprising:

8. 8. The system of claim 7, wherein each burst cycle is represented by a period between actuation of a drive mechanism and begins and ends upon cessation of actuation of the drive mechanism.

9. The system of claim 7 , wherein the trend line is fitted to an average value of the pressure sensed upon cessation of actuation of the drive mechanism.

10. The system of claim 7 , wherein a positive slope of the trend line indicates an occlusion.

11. Estimating system compliance; and Calculating the probability of system blockage; triggering at least one of a blockage alert, alarm, or notification upon determining that the calculated probability of system blockage exceeds a threshold; 23. A method for detecting an occlusion comprising:

12. The method of claim 11 , wherein the system compliance is calculated by measuring reduced pressure after deactivation of the drive mechanism.

13. The method of claim 11 , wherein the system compliance is calculated as a function of a predicted damping of friction forces.

14. The method of claim 11 , wherein the system compliance is calculated by dividing the change in pressure measured by a force sensor by the change in fluid volume.

15. The method of claim 11 , wherein calculating the probability of a blockage of the system comprises Bayesian inference.